| 000 | 01601 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513113129.0 | ||
| 264 | 0 | _c19970603 | |
| 008 | 199706s 0 0 eng d | ||
| 022 | _a0391-3988 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGerlach, M | |
| 245 | 0 | 0 |
_aGlobal and extended coagulation monitoring during extracorporeal lung assist with heparin-coated systems in ARDS patients. _h[electronic resource] |
| 260 |
_bThe International journal of artificial organs _cJan 1997 |
||
| 300 |
_a29-36 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAnticoagulants _xpharmacology |
| 650 | 0 | 4 |
_aAntithrombin III _xdrug effects |
| 650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
| 650 | 0 | 4 |
_aExtracorporeal Circulation _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinogen _xmetabolism |
| 650 | 0 | 4 |
_aHeparin _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung _xblood supply |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMembranes, Artificial |
| 650 | 0 | 4 | _aMonitoring, Physiologic |
| 650 | 0 | 4 | _aPartial Thromboplastin Time |
| 650 | 0 | 4 |
_aPeptide Hydrolases _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aRespiratory Distress Syndrome _xphysiopathology |
| 650 | 0 | 4 |
_aThromboembolism _xmortality |
| 700 | 1 | _aFöhre, B | |
| 700 | 1 | _aKeh, D | |
| 700 | 1 | _aRiess, H | |
| 700 | 1 | _aFalke, K J | |
| 700 | 1 | _aGerlach, H | |
| 773 | 0 |
_tThe International journal of artificial organs _gvol. 20 _gno. 1 _gp. 29-36 |
|
| 999 |
_c9050637 _d9050637 |
||